The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...

Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug ...

We recently published Market on Mute? Not for These 10 Stocks With Surprising Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is ...

Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...

Wall Street’s main indices finished in the green but with lackluster gains, with the Nasdaq rising 0.27 percent, the S&P 500 ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...

Andrew Wright is a Newsweek contributor based in Lancaster, South Carolina. His focus is MLB content. Andrew has been with Newsweek since April 1st and previously worked at Yardbarker, SEC ...

Andrew Schneider is the senior reporter for politics and government at Houston Public Media, NPR’s affiliate station in Houston, Texas. In this capacity, he heads the station’s coverage of ...

Andrew Van Dam writes the Department of Data column each week for The Washington Post. He has covered economics and wrangled data and graphics for The Post and the Wall Street Journal.

Andrew Gomes is a business reporter at the Honolulu Star-Advertiser. Gomes is a longtime Hawaii journalist who for most of his career has concentrated on business subjects with a particular focus ...